In our patient cohort, 6.5% of ME/CFS patients had reduced IgA levels (<7 mg/dL) and 2.7% even had selective IgA deficiency. This evidence concerns the gene CD79A and myalgic encephalomeyelitis/chronic fatigue syndrome.